[go: up one dir, main page]

AU2002212941A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
AU2002212941A1
AU2002212941A1 AU2002212941A AU1294102A AU2002212941A1 AU 2002212941 A1 AU2002212941 A1 AU 2002212941A1 AU 2002212941 A AU2002212941 A AU 2002212941A AU 1294102 A AU1294102 A AU 1294102A AU 2002212941 A1 AU2002212941 A1 AU 2002212941A1
Authority
AU
Australia
Prior art keywords
novel compounds
substituted
triazolo
pyrimidines
medicaments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002212941A
Inventor
Simon Guile
Barrie Martin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2002212941A1 publication Critical patent/AU2002212941A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)

Abstract

The invention provides novel substituted cyclopentane compounds (in particular, substituted [1,2,3]triazolo[4,5-d]pyrimidines), their use as medicaments (in particular, their use as anti-thrombotic agents), compositions containing them and processes for their preparation.
AU2002212941A 2000-11-09 2001-11-07 Novel compounds Abandoned AU2002212941A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0004098A SE0004098D0 (en) 2000-11-09 2000-11-09 Novel compounds
SE0004098 2000-11-09
PCT/SE2001/002472 WO2002038571A1 (en) 2000-11-09 2001-11-07 Novel compounds

Publications (1)

Publication Number Publication Date
AU2002212941A1 true AU2002212941A1 (en) 2002-05-21

Family

ID=20281755

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002212941A Abandoned AU2002212941A1 (en) 2000-11-09 2001-11-07 Novel compounds

Country Status (9)

Country Link
US (2) US6844348B2 (en)
EP (1) EP1335918B1 (en)
JP (1) JP4190282B2 (en)
AT (1) ATE339420T1 (en)
AU (1) AU2002212941A1 (en)
DE (1) DE60123103T2 (en)
ES (1) ES2271083T3 (en)
SE (1) SE0004098D0 (en)
WO (1) WO2002038571A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060004107A1 (en) * 2004-07-02 2006-01-05 Masanori Ojima Method for designing a pharmaceutical compound specific to a desired receptor, a designed compound thereby, and pharmaceutical compositions containing the same
DE102008002471A1 (en) * 2008-06-17 2009-12-24 Biotronik Vi Patent Ag Stent with a coating or a base body containing a lithium salt, and use of lithium salts for restenosis prophylaxis
CN102653539B (en) * 2011-03-01 2014-09-17 秦引林 Compound for resisting platelet aggregation and medicament combination thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR017014A1 (en) * 1997-07-22 2001-08-22 Astrazeneca Ab TRIAZOL COMPOUNDS [4,5-D] PYRIMIDINE, PHARMACEUTICAL COMPOSITIONS, USE OF THE SAME TO PREPARE MEDICATIONS AND PROCESSES FOR THE PREPARATION OF SUCH COMPOUNDS

Also Published As

Publication number Publication date
JP4190282B2 (en) 2008-12-03
ES2271083T3 (en) 2007-04-16
EP1335918A1 (en) 2003-08-20
EP1335918B1 (en) 2006-09-13
HK1056361A1 (en) 2004-02-13
WO2002038571A1 (en) 2002-05-16
JP2004513173A (en) 2004-04-30
ATE339420T1 (en) 2006-10-15
US20050143399A1 (en) 2005-06-30
US6844348B2 (en) 2005-01-18
US7345047B2 (en) 2008-03-18
US20040029899A1 (en) 2004-02-12
DE60123103D1 (en) 2006-10-26
DE60123103T2 (en) 2007-03-15
SE0004098D0 (en) 2000-11-09

Similar Documents

Publication Publication Date Title
UA66801C2 (en) Novel compounds
AU2002305143A1 (en) Pyrazolo'1,5-a!pyridine derivatives
WO2003095455A3 (en) Substituted pyrazolopyrimidines
AU2002341920A1 (en) Chemical compounds
ID24837A (en) SENYAWA TRIAZOLO [4,5-D] PYRIMIDINE, USE, COMPOSITION AND PROCESSING
WO2002048147A3 (en) Pyrazolopyridines
MY140674A (en) New crystalline form of a triazolo(4,5-d)pyrimidine compound
WO2004074244A3 (en) Pyrimidine compounds
TR200101567T2 (en) New triazolo (4.5-D) pyrimidine compositions.
WO2001098236A3 (en) 7-phenyl-substituted tetracycline compounds
WO2002048148A3 (en) Pyrazolopyridine derivatives
WO2001027118A3 (en) Bicyclic imidazo-5-yl-amine derivatives
WO2004106339A3 (en) 4-SUBSTITUTED DERIVATIVES OF PYRAZOLO [3,4-d] PYRIMIDINE AND PYRROLO [2,3-d] PYRIMIDINE AND USES THEREOF
AU2003217712A1 (en) Pyrazolopyrimidine and pyrazolotriazine derivatives and pharmaceutical compositions containing them
WO2001098275A3 (en) 1-aryl-4-oxo-1,4-dihydro-3-quinolinecarboxamides as antiviral agents
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
AU2001289714A1 (en) Benzofuran derivatives and their use as antibacterial agents
AU5539899A (en) Novel triazolo(4,5-(d))pyrimidine compounds
MXPA04001773A (en) 3-substituted 6,7-dihydroxytetrahydroisoquinoline derivatives for use as antibacterial agents.
AU2002248531A1 (en) Pyrazolopyriadine derivatives
AU2002212941A1 (en) Novel compounds
HUP0303486A3 (en) Compositions containing 3,7-diazabicyclo [3,3,1] compounds as anti-arrythmic compounds agents
AU2002214467A1 (en) Novel compounds
EP1436279B8 (en) Chemical compounds
AU2001232865A1 (en) Isocyanate compositions containing d-limonene